10/14/2013

European regulators have granted Sanofi CE mark approval for its JuniorSTAR insulin pen, designed for use in type 1 diabetes patients 6 to 18 years of age. The reusable device supports half-unit dosing increments and works with Insuman, Lantus and Apidra, allowing more insulin dosing flexibility for health care providers.

Full Story:
MedGadget.com

Related Summaries